United States Biotechnology & Medical Research

UNITY Biotechnology Inc (UBX)

Track

Insider trading activity at UNITY Biotechnology Inc. has consisted exclusively of planned and proposed sales by key executives, including the CEO, CFO, and CLO. The most recent transactions occurred on April 2, 2025. These sales were conducted as part of routine, pre-arranged trading plans rather than discretionary market activity.
Ticker: UBX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Proposed sale 2 Apr 2025
Value US$1,895,755.90 | Price 25.78 | Shares 90,080
Planned sale 2 Apr 2025
Value US$1,501,867.95 | Price 383.88 | Shares 65,380 (+25.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-04-03 2025-04-02 PrS Proposed sale
Nguyen Alexander Hieu

Officer

Officer
90,080
25.78
US$1,895,756 		90,080 25.78 US$1,895,756
2025-04-03 2025-04-02 PrS Proposed sale
Sullivan Lynne Marie

Officer

Officer
90,883
347.45
US$3,155,030 		90,883 347.45 US$3,155,030
2025-04-03 2025-04-02 PrS Proposed sale
Ghosh Anirvan

Officer; Director

Executive Director
9,888
210.14
US$1,868,297 		9,888 210.14 US$1,868,297
2025-04-03 2025-04-02 PlS Planned sale
Nguyen Alexander Hieu

CLO and Head of Ops

Officer
17,852 -26.8%
1.03
US$18,388 		17,852 -26.8% 1.03 US$18,388
2025-04-03 2025-04-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
96,797 -38.7%
1.03
US$99,701 		96,797 -38.7% 1.03 US$99,701
2025-04-03 2025-04-02 PlS Planned sale
Sullivan Lynne Marie

CFO & Head of Corp. Dev.

Officer
21,867 -18.1%
1.03
US$22,523 		21,867 -18.1% 1.03 US$22,523
2025-03-31 2025-03-27 PlS Planned sale
Nguyen Alexander Hieu

CLO and Head of Ops

Officer
1,954 -8.0%
1.16
US$2,267 		1,954 -8.0% 1.16 US$2,267
2025-02-05 2025-02-04 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
642 -0.8%
2.23
US$1,432 		642 -0.8% 2.23 US$1,432
2025-02-05 2025-02-04 PlS Planned sale
Nguyen Alexander Hieu

CLO and Head of Ops

Officer
164 -0.7%
2.23
US$366 		164 -0.7% 2.23 US$366
2025-02-05 2025-02-04 PlS Planned sale
Sullivan Lynne Marie

CFO & Head of Corp. Dev.

Officer
153 -0.3%
2.23
US$341 		153 -0.3% 2.23 US$341
2024-11-06 2024-11-04 PlS Planned sale
Nguyen Alexander Hieu

Chief Legal Officer

Officer
149 -0.6%
1.29
US$192 		149 -0.6% 1.29 US$192
2024-11-06 2024-11-04 PlS Planned sale
Sullivan Lynne Marie

CFO & Head of Corp. Dev.

Officer
136 -0.2%
1.29
US$175 		136 -0.2% 1.29 US$175
2024-11-06 2024-11-04 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
432 -0.6%
1.29
US$557 		432 -0.6% 1.29 US$557
2024-08-06 2024-08-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
604 -0.8%
1.53
US$924 		604 -0.8% 1.53 US$924
2024-08-06 2024-08-02 PlS Planned sale
Nguyen Alexander Hieu

Chief Legal Officer

Officer
154 -0.6%
1.53
US$236 		154 -0.6% 1.53 US$236
2024-08-06 2024-08-02 PlS Planned sale
Sullivan Lynne Marie

CFO & Head of Corp. Dev.

Officer
139 -0.2%
1.53
US$213 		139 -0.2% 1.53 US$213
2024-06-26 2024-06-25 PlS Planned sale
Nguyen Alexander Hieu

Chief Legal Officer

Officer
78 -0.3%
1.40
US$109 		78 -0.3% 1.40 US$109
2024-06-26 2024-06-25 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,214 -1.6%
1.40
US$1,700 		1,214 -1.6% 1.40 US$1,700
2024-06-26 2024-06-25 PlS Planned sale
Sullivan Lynne Marie

CFO & Head of Corp. Dev.

Officer
324 -1.0%
1.40
US$454 		324 -1.0% 1.40 US$454
2024-05-03 2024-05-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
603 -0.8%
1.55
US$935 		603 -0.8% 1.55 US$935
2024-02-05 2024-02-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
680 -0.9%
1.71
US$1,163 		680 -0.9% 1.71 US$1,163
2024-01-31 2024-01-30 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,183 -1.5%
1.71
US$2,023 		1,183 -1.5% 1.71 US$2,023
2023-11-03 2023-11-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
589 -0.7%
1.83
US$1,078 		589 -0.7% 1.83 US$1,078
2023-10-31 2023-10-30 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,024 -1.2%
1.90
US$1,946 		1,024 -1.2% 1.90 US$1,946
2023-09-15 2023-09-14 PrS Proposed sale
Ghosh Anirvan

Officer; Director

Executive Director
1,246
2.47
US$3,079 		1,246 2.47 US$3,079
2023-09-15 2023-09-14 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,246 -1.5%
2.47
US$3,078 		1,246 -1.5% 2.47 US$3,078
2023-08-03 2023-08-02 PrS Proposed sale
Ghosh Anirvan

Officer; Director

Executive Director
581
2.94
US$1,708 		581 2.94 US$1,708
2023-08-03 2023-08-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
581 -0.7%
2.94
US$1,708 		581 -0.7% 2.94 US$1,708
2023-08-01 2023-07-31 PrS Proposed sale
Ghosh Anirvan

Officer; Director

Executive Director
1,020
2.86
US$2,917 		1,020 2.86 US$2,917
2023-08-01 2023-07-31 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Officer
1,020 -1.2%
2.86
US$2,917 		1,020 -1.2% 2.86 US$2,917
2023-06-27 2023-06-26 PrS Proposed sale
Anirvan Ghosh

Officer

Officer
1,177
3.20
US$3,767 		1,177 3.20 US$3,767
2023-06-27 2023-06-26 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,177 -1.4%
3.20
US$3,766 		1,177 -1.4% 3.20 US$3,766
2023-06-15 2023-06-14 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,212 -1.4%
3.39
US$4,109 		1,212 -1.4% 3.39 US$4,109
2023-06-14 2023-06-14 PrS Proposed sale
Anirvan Ghosh

Officer

Officer
1,212
3.39
US$4,109 		1,212 3.39 US$4,109
2023-05-03 2023-05-02 PrS Proposed sale
Anirvan Ghosh

Officer

Officer
588
2.17
US$1,276 		588 2.17 US$1,276
2023-05-03 2023-05-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
588 -0.7%
2.17
US$1,276 		588 -0.7% 2.17 US$1,276
2023-05-02 2023-05-01 PrS Proposed sale
Anirvan Ghosh

Officer; Director

Executive Director
1,020
2.15
US$2,193 		1,020 2.15 US$2,193
2023-05-02 2023-05-01 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,020 -92.1%
2.15
US$2,193 		1,020 -92.1% 2.15 US$2,193
2023-04-03 2023-03-31 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,959 -2.2%
1.70
US$3,330 		1,959 -2.2% 1.70 US$3,330
2023-04-03 2023-03-31 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
420 -0.7%
1.70
US$714 		420 -0.7% 1.70 US$714
2023-03-15 2023-03-14 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,210 -1.3%
4.00
US$4,840 		1,210 -1.3% 4.00 US$4,840
2023-03-15 2023-03-14 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
1,005 -1.6%
4.00
US$4,020 		1,005 -1.6% 4.00 US$4,020
2023-02-03 2023-02-02 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
2,573 -2.7%
4.84
US$12,453 		2,573 -2.7% 4.84 US$12,453
2023-02-03 2023-02-02 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
863 -1.3%
4.84
US$4,177 		863 -1.3% 4.84 US$4,177
2023-01-31 2023-01-30 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,140 -1.2%
4.45
US$5,073 		1,140 -1.2% 4.45 US$5,073
2022-12-15 2022-12-14 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,274 -1.3%
2.85
US$3,631 		1,274 -1.3% 2.85 US$3,631
2022-12-15 2022-12-14 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
1,016 -1.5%
2.85
US$2,896 		1,016 -1.5% 2.85 US$2,896
2022-11-04 2022-11-03 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
1,099 -1.1%
2.40
US$2,638 		1,099 -1.1% 2.40 US$2,638
2022-09-15 2022-09-14 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
13,706 -1.4%
0.48
US$6,579 		13,706 -1.4% 0.48 US$6,579
2022-09-15 2022-09-14 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
10,923 -1.6%
0.48
US$5,243 		10,923 -1.6% 0.48 US$5,243
2022-08-02 2022-08-01 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
10,446 -1.0%
0.67
US$6,999 		10,446 -1.0% 0.67 US$6,999
2022-06-28 2022-06-27 PlS Planned sale
Ghosh Anirvan

Chief Executive Officer

Executive Director
12,149 -1.2%
0.59
US$7,168 		12,149 -1.2% 0.59 US$7,168
2022-06-28 2022-06-27 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
4,398 -0.7%
0.59
US$2,595 		4,398 -0.7% 0.59 US$2,595
2022-06-22 2022-06-21 PlS Planned sale
2.9
Dananberg Jamie

Chief Medical Officer

Officer
3,697 -0.5%
0.62
US$2,292 		3,697 -0.5% 0.62 US$2,292
2020-12-18 2020-12-16 S Sale
0.7
David Nathaniel E

President

Executive Director
1,700,000 -73.1%
5.24
US$8,908,000 		1,700,000 -73.1% 5.24 US$8,908,000
2020-06-09 2020-06-05 B Purchase
0.7
David Nathaniel E

President

Executive Director
3,200 +0.1%
8.90
US$28,478 		3,200 +0.1% 8.90 US$28,478
Explore more

More insider trading research around UNITY Biotechnology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America